Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.00 (0.00%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

25 Jun 2015 13:57

TATE & LYLE PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the ‘Company’) has been informed that today Robert Gibber, a Person Discharging Managerial Responsibility, exercised 22,350 nil-cost options over ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the 2003 Performance Share Plan (‘PSP’), of which 10,542 Shares were sold at 538.50 pence per Share to pay for tax and sales costs. Mr Gibber retained the remaining Shares.

No consideration was paid for the acquisition of these Shares. Awards made under the PSP are subject to the satisfaction of performance conditions over a three year performance period, which in this case was 1 April 2012 to 31 March 2015.

All transactions occurred on the London Stock Exchange.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Jaime Tham

Deputy Company Secretary

25 June 2015

View source version on businesswire.com: http://www.businesswire.com/news/home/20150625005694/en/

Copyright Business Wire 2015

Date   Source Headline
15th Nov 20245:30 pmRNSTransaction in Own Shares
15th Nov 20243:13 pmRNSCompletion of Combination Tate & Lyle and CP Kelco
14th Nov 20245:48 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:45 pmRNSTransaction in Own Shares
11th Nov 20245:37 pmRNSTransaction in Own Shares
8th Nov 20245:29 pmRNSTransaction in Own Shares
7th Nov 20245:31 pmRNSTransaction in Own Shares
7th Nov 20247:00 amRNSHalf-year Report
6th Nov 20245:44 pmRNSTransaction in Own Shares
5th Nov 20245:20 pmRNSTransaction in Own Shares
5th Nov 20241:00 pmRNSHolding(s) in Company
4th Nov 20245:28 pmRNSTransaction in Own Shares
1st Nov 20245:44 pmRNSTransaction in Own Shares
1st Nov 202412:15 pmRNSTotal Voting Rights
31st Oct 20245:28 pmRNSTransaction in Own Shares
30th Oct 20245:33 pmRNSTransaction in Own Shares
29th Oct 20245:27 pmRNSTransaction in Own Shares
28th Oct 20245:40 pmRNSTransaction in Own Shares
28th Oct 20244:30 pmRNSHolding(s) in Company
25th Oct 20245:25 pmRNSTransaction in Own Shares
24th Oct 20245:31 pmRNSTransaction in Own Shares
23rd Oct 20245:19 pmRNSTransaction in Own Shares
23rd Oct 202411:00 amRNSHolding(s) in Company
22nd Oct 20245:28 pmRNSTransaction in Own Shares
22nd Oct 202412:45 pmRNSTotal Voting Rights
21st Oct 20245:36 pmRNSTransaction in Own Shares
18th Oct 20245:46 pmRNSTransaction in Own Shares
17th Oct 20245:40 pmRNSTransaction in Own Shares
16th Oct 20245:20 pmRNSTransaction in Own Shares
15th Oct 20245:23 pmRNSTransaction in Own Shares
14th Oct 20245:29 pmRNSTransaction in Own Shares
11th Oct 20245:38 pmRNSTransaction in Own Shares
10th Oct 20245:36 pmRNSTransaction in Own Shares
9th Oct 20245:26 pmRNSTransaction in Own Shares
8th Oct 20245:32 pmRNSTransaction in Own Shares
7th Oct 20245:41 pmRNSTransaction in Own Shares
4th Oct 20245:58 pmRNSTransaction in Own Shares
3rd Oct 20245:34 pmRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSInformation - combination Tate & Lyle / CP Kelco
2nd Oct 20245:47 pmRNSTransaction in Own Shares
1st Oct 20245:32 pmRNSTransaction in Own Shares
1st Oct 202412:00 pmRNSTotal Voting Rights
30th Sep 20245:25 pmRNSTransaction in Own Shares
27th Sep 20245:49 pmRNSTransaction in Own Shares
26th Sep 20245:33 pmRNSTransaction in Own Shares
25th Sep 20245:33 pmRNSTransaction in Own Shares
24th Sep 20243:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20245:45 pmRNSTransaction in Own Shares
20th Sep 20245:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.